Predictive value of pulse oximetry for mortality in infants and children presenting to primary care with clinical pneumonia in rural Malawi: A data linkage study.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
10 2020
Historique:
received: 14 02 2020
accepted: 11 09 2020
entrez: 23 10 2020
pubmed: 24 10 2020
medline: 22 12 2020
Statut: epublish

Résumé

The mortality impact of pulse oximetry use during infant and childhood pneumonia management at the primary healthcare level in low-income countries is unknown. We sought to determine mortality outcomes of infants and children diagnosed and referred using clinical guidelines with or without pulse oximetry in Malawi. We conducted a data linkage study of prospective health facility and community case and mortality data. We matched prospectively collected community health worker (CHW) and health centre (HC) outpatient data to prospectively collected hospital and community-based mortality surveillance outcome data, including episodes followed up to and deaths within 30 days of pneumonia diagnosis amongst children 0-59 months old. All data were collected in Lilongwe and Mchinji districts, Malawi, from January 2012 to June 2014. We determined differences in mortality rates using <90% and <93% oxygen saturation (SpO2) thresholds and World Health Organization (WHO) and Malawi clinical guidelines for referral. We used unadjusted and adjusted (for age, sex, respiratory rate, and, in analyses of HC data only, Weight for Age Z-score [WAZ]) regression to account for interaction between SpO2 threshold (pulse oximetry) and clinical guidelines, clustering by child, and CHW or HC catchment area. We matched CHW and HC outpatient data to hospital inpatient records to explore roles of pulse oximetry and clinical guidelines on hospital attendance after referral. From 7,358 CHW and 6,546 HC pneumonia episodes, we linked 417 CHW and 695 HC pneumonia episodes to 30-day mortality outcomes: 16 (3.8%) CHW and 13 (1.9%) HC patients died. SpO2 thresholds of <90% and <93% identified 1 (6%) of the 16 CHW deaths that were unidentified by integrated community case management (iCCM) WHO referral protocol and 3 (23%) and 4 (31%) of the 13 HC deaths, respectively, that were unidentified by the integrated management of childhood illness (IMCI) WHO protocol. Malawi IMCI referral protocol, which differs from WHO protocol at the HC level and includes chest indrawing, identified all but one of these deaths. SpO2 < 90% predicted death independently of WHO danger signs compared with SpO2 ≥ 90%: HC Risk Ratio (RR), 9.37 (95% CI: 2.17-40.4, p = 0.003); CHW RR, 6.85 (1.15-40.9, p = 0.035). SpO2 < 93% was also predictive versus SpO2 ≥ 93% at HC level: RR, 6.68 (1.52-29.4, p = 0.012). Hospital referrals and outpatient episodes with referral decision indications were associated with mortality. A substantial proportion of those referred were not found admitted in the inpatients within 7 days of referral advice. All 12 deaths in 73 hospitalised children occurred within 24 hours of arrival in the hospital, which highlights delay in appropriate care seeking. The main limitation of our study was our ability to only match 6% of CHW episodes and 11% of HC episodes to mortality outcome data. Pulse oximetry identified fatal pneumonia episodes at HCs in Malawi that would otherwise have been missed by WHO referral guidelines alone. Our findings suggest that pulse oximetry could be beneficial in supplementing clinical signs to identify children with pneumonia at high risk of mortality in the outpatient setting in health centres for referral to a hospital for appropriate management.

Sections du résumé

BACKGROUND
The mortality impact of pulse oximetry use during infant and childhood pneumonia management at the primary healthcare level in low-income countries is unknown. We sought to determine mortality outcomes of infants and children diagnosed and referred using clinical guidelines with or without pulse oximetry in Malawi.
METHODS AND FINDINGS
We conducted a data linkage study of prospective health facility and community case and mortality data. We matched prospectively collected community health worker (CHW) and health centre (HC) outpatient data to prospectively collected hospital and community-based mortality surveillance outcome data, including episodes followed up to and deaths within 30 days of pneumonia diagnosis amongst children 0-59 months old. All data were collected in Lilongwe and Mchinji districts, Malawi, from January 2012 to June 2014. We determined differences in mortality rates using <90% and <93% oxygen saturation (SpO2) thresholds and World Health Organization (WHO) and Malawi clinical guidelines for referral. We used unadjusted and adjusted (for age, sex, respiratory rate, and, in analyses of HC data only, Weight for Age Z-score [WAZ]) regression to account for interaction between SpO2 threshold (pulse oximetry) and clinical guidelines, clustering by child, and CHW or HC catchment area. We matched CHW and HC outpatient data to hospital inpatient records to explore roles of pulse oximetry and clinical guidelines on hospital attendance after referral. From 7,358 CHW and 6,546 HC pneumonia episodes, we linked 417 CHW and 695 HC pneumonia episodes to 30-day mortality outcomes: 16 (3.8%) CHW and 13 (1.9%) HC patients died. SpO2 thresholds of <90% and <93% identified 1 (6%) of the 16 CHW deaths that were unidentified by integrated community case management (iCCM) WHO referral protocol and 3 (23%) and 4 (31%) of the 13 HC deaths, respectively, that were unidentified by the integrated management of childhood illness (IMCI) WHO protocol. Malawi IMCI referral protocol, which differs from WHO protocol at the HC level and includes chest indrawing, identified all but one of these deaths. SpO2 < 90% predicted death independently of WHO danger signs compared with SpO2 ≥ 90%: HC Risk Ratio (RR), 9.37 (95% CI: 2.17-40.4, p = 0.003); CHW RR, 6.85 (1.15-40.9, p = 0.035). SpO2 < 93% was also predictive versus SpO2 ≥ 93% at HC level: RR, 6.68 (1.52-29.4, p = 0.012). Hospital referrals and outpatient episodes with referral decision indications were associated with mortality. A substantial proportion of those referred were not found admitted in the inpatients within 7 days of referral advice. All 12 deaths in 73 hospitalised children occurred within 24 hours of arrival in the hospital, which highlights delay in appropriate care seeking. The main limitation of our study was our ability to only match 6% of CHW episodes and 11% of HC episodes to mortality outcome data.
CONCLUSIONS
Pulse oximetry identified fatal pneumonia episodes at HCs in Malawi that would otherwise have been missed by WHO referral guidelines alone. Our findings suggest that pulse oximetry could be beneficial in supplementing clinical signs to identify children with pneumonia at high risk of mortality in the outpatient setting in health centres for referral to a hospital for appropriate management.

Identifiants

pubmed: 33095763
doi: 10.1371/journal.pmed.1003300
pii: PMEDICINE-D-20-00470
pmc: PMC7584207
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003300

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Wellcome Trust
ID : WT091909/B/10/Z0
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet Infect Dis. 2020 Jan;20(1):60-79
pubmed: 31678026
Lancet Glob Health. 2018 Sep;6(9):e1036-e1044
pubmed: 30103981
BMC Pediatr. 2015 Nov 17;15:186
pubmed: 26577943
Cochrane Database Syst Rev. 2013 Jun 04;(6):CD004874
pubmed: 23733365
PLoS One. 2015 Sep 15;10(9):e0136166
pubmed: 26372640
Am J Trop Med Hyg. 2020 Mar;102(3):676-683
pubmed: 31971153
CMAJ. 2012 May 15;184(8):895-9
pubmed: 22158397
Nat Microbiol. 2019 Dec;4(12):2310-2318
pubmed: 31570869
Bull World Health Organ. 2008 May;86(5):332-8
pubmed: 18545734
Lancet Glob Health. 2018 Jan;6(1):e8-e9
pubmed: 29241619
Arch Dis Child. 2020 Jul;105(7):616-617
pubmed: 32424004
Am J Trop Med Hyg. 2019 Sep;101(3):670-675
pubmed: 31287044
Lancet Glob Health. 2019 Jan;7(1):e47-e57
pubmed: 30497986
Pediatrics. 2017 Sep;140(3):
pubmed: 28835381
Ann Trop Paediatr. 2009 Dec;29(4):281-9
pubmed: 19941751
Arch Dis Child. 2016 Aug;101(8):694-700
pubmed: 26699537
PLoS One. 2016 Dec 28;11(12):e0168126
pubmed: 28030608
Vaccine. 2015 Sep 11;33(38):4748-55
pubmed: 26235370
N Engl J Med. 2020 Jul 2;383(1):13-23
pubmed: 32609979
Lancet Glob Health. 2018 Jan;6(1):e74-e83
pubmed: 29241618
BMC Public Health. 2015 Sep 30;15:989
pubmed: 26419934
J Clin Epidemiol. 2003 Nov;56(11):1129-35
pubmed: 14615004
PLoS One. 2017 Jan 4;12(1):e0168209
pubmed: 28052071
J Glob Health. 2019 Jun;9(1):010807
pubmed: 31263552
Vaccine. 2015 May 28;33(23):2637-45
pubmed: 25917672
Clin Infect Dis. 2015 Apr 15;60(8):1216-24
pubmed: 25550349
Nature. 2015 Dec 3;528(7580):S53-9
pubmed: 26633766
Malawi Med J. 2014 Dec;26(4):126-32
pubmed: 26167263

Auteurs

Tim Colbourn (T)

Institute for Global Health, University College London, London, United Kingdom.

Carina King (C)

Institute for Global Health, University College London, London, United Kingdom.
Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

James Beard (J)

Institute for Global Health, University College London, London, United Kingdom.

Tambosi Phiri (T)

Parent and Child Health Initiative, Lilongwe, Malawi.

Malizani Mdala (M)

Parent and Child Health Initiative, Lilongwe, Malawi.

Beatiwel Zadutsa (B)

Parent and Child Health Initiative, Lilongwe, Malawi.

Charles Makwenda (C)

Parent and Child Health Initiative, Lilongwe, Malawi.

Anthony Costello (A)

Institute for Global Health, University College London, London, United Kingdom.

Norman Lufesi (N)

Ministry of Health, Lilongwe, Malawi.

Charles Mwansambo (C)

Ministry of Health, Lilongwe, Malawi.

Bejoy Nambiar (B)

UNICEF, Lilongwe, Malawi.

Shubhada Hooli (S)

Department of Pediatrics, Section of Emergency Medicine, Baylor College of Medicine, Houston, Texas, United States of America.

Neil French (N)

Institute of Infection & Global Health, University of Liverpool, Liverpool, United Kingdom.

Naor Bar Zeev (N)

Institute of Infection & Global Health, University of Liverpool, Liverpool, United Kingdom.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Shamim Ahmad Qazi (SA)

Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva, Switzerland.

Yasir Bin Nisar (Y)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Eric D McCollum (ED)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Global Program in Pediatric Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH